Table 3.
Standardized costs by treatment groups in US dollars.
| Control (n = 1958) | Intervention (n = 196) | Difference | 95%-CI | p-Value | |||
|---|---|---|---|---|---|---|---|
| Mean (SD) |
Median (Q1, Q3) |
Mean (SD) |
Median (Q1, Q3) |
||||
| Total billed charges for any reason |
69.3 (179) | 20.1 (6.7, 61.9) | 61.3 (103) | 22.2 (8.5, 74.1) | −8.04 | −24.5 to 8.4 | 0.36 |
| Cost of hospitalizations due to COVID-19 |
0.56 (12.5) | 0 (0, 0) | 0 (0) | 0 (0, 0) | −0.56 | −2.3 to 1.2 | 0.48 |
| Cost of ICU admissions due to COVID-19 |
0.33 (8.9) | 0 (0, 0) | 0 (0) | 0 (0, 0) | −0.33 | −0.72 to 0.06 | 0.58 |
| Cost of ventilator use due to COVID-19 (zeros entry) |
|||||||
| Medical pharmacy prescription costs for any reason |
6.4 (92.4) | 0 (0, 0) | 7.4 (51.4) | 0 (0, 0) | 1.05 | −7.3 to 9.4 | 0.52 |
| Freestanding prescription costs for any reason |
9.05 (38.3) | 1.4 (0.2, 5.4) | 13.4 (34.9) | 1.6 (0.4, 8.1) | 4.4 | −1.2 to 9.9 | 0.07 |
SD—standard deviation; CI—confidence interval. Difference uses control group as reference.